Halozyme Therapeutics, Inc. (0J2O.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 04:01PM GMT
| Previous close | 32.79 |
| Open | 32.55 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 32.55 - 33.05 |
| 52-week range | 32.55 - 33.05 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 5.308B |
| Beta (5Y monthly) | 1.46 |
| PE ratio (TTM) | 29.10 |
| EPS (TTM) | 1.13 |
| Earnings date | 21 Feb 2022 - 25 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Halozyme Therapeutics (HALO) Down 19.7% Since Last Earnings Report: Can It Rebound?
Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Simply Wall St.
Here's Why I Think Halozyme Therapeutics (NASDAQ:HALO) Is An Interesting Stock
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
- Zacks
Halozyme (HALO) Beats on Q3 Earnings, Tweaks 2021 Guidance
Halozyme (HALO) third-quarter earnings and sales beat estimates. The company raises the lower end of its previously guided range for earnings and revenues for 2021. Stock up.
© 2021 Yahoo. All rights reserved.
